Home/Filings/4/0001181431-06-038225
4//SEC Filing

HOPKINS CAPITAL GROUP LLC 4

Accession 0001181431-06-038225

CIK 0001310094other

Filed

Jun 22, 8:00 PM ET

Accepted

Jun 23, 2:36 PM ET

Size

5.1 KB

Accession

0001181431-06-038225

Insider Transaction Report

Form 4
Period: 2006-04-03
Transactions
  • Other

    Common Stock

    2006-04-03$8.00/sh+4,333$34,6644,385,992 total
Footnotes (1)
  • [F1]Represents the receipt of shares of common stock in lieu of accrued but unpaid dividends on the Company's former Series E Convertible Preferred Stock at a price of $8.00 a share.

Issuer

ACCENTIA BIOPHARMACEUTICALS INC

CIK 0001310094

Entity typeother

Related Parties

1
  • filerCIK 0001250417

Filing Metadata

Form type
4
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 2:36 PM ET
Size
5.1 KB